1. Home
  2. Publications
  1. Synthesis of Highly Substituted Pyrrolo[1,2-a]quinoline-3,5-diones through Ag(I) Catalyzed Cyclization of 4-Hydroxyquinolinyl-2-ynones, Jais Kurian and Muraleedharan K. Manheri, Eur. J. Org. Chem. 2023, 26, 46, e202300894
  2. Hybridization of the Pharmacophoric Features of Discoipyrrole C and Combretastatin A-4 toward New Anticancer Leads, Jais Kurian, Anvesh Ashtam, Akila Kesavan, Saheer V. Chaluvalappil, Dulal Panda and Muraleedharan K. Manheri, ChemMedChem, 2023; e202300081; doi: 10.1002/cmdc.202300081.
  3. A dual mode ‘turn-on’ fluorescence-Raman (SERS) response probe based on a 1H-pyrrol-3(2H)-one scaffold for monitoring H2S levels in biological samples, Archana Panthalattu Parambil, Shanmughan Shamjith, Jais Kurian, Akila Kesavan, Ashis K. Sen, Paul R. Thangaraj, Kaustabh Kumar Maiti and Muraleedharan K. Manheri, Analytical Methods, 2023, 15, 2853 – 2860
  4. Cancer cell uptake and distribution of oxanorbornane-based synthetic lipids and their prospects as novel drug delivery systems, Akila Kesavan, U. Chandrasekhar Reddy, Jais Kurian and Muraleedharan Kannoth M. Journal of Drug Delivery Science and Technology, 2022, 73, 103439.
  5. Adenine-modification at C-7 as a promising strategy to potentiate the antimalarial activity of quinolones, Jais Kurian, Varsha Kumari, Saheer, V. Chaluvalappil, Mohammad Anas, Ashan Manhas, Ramshad Kalluruttimmal, Niti Kumar, Muraleedharan K. Manheri, ChemMedChem, 2022, 17, e202100472 (DOI: 10.1002/cmdc.202100472)
  6. Delocalization Effects and Tunable Emission in a Class of Charged Cyclazines with Nitrogen on the Periphery, Jais Kurian, Kanneth S. Shurooque, Venkatachalam Ramkumar, Lakshmi Chakkumkumarath, and Muraleedharan Kannoth M., Org. Lett. 2021, 23, 9, 3354–3358.
  7. Reactive Pt(II) center as part of redox-active quinoline-based heterocyclic scaffolds toward new anticancer leads, Sateeshkumar Kumbhakonam, Soumya Saroj , Nalini Venkatesan , Karunagaran Devarajan , Muraleedharan K. Manheri, Bioorg. Med. Chem. Lett., 2020, 30 (22), 127594 -127599.
  8. Benzisothiazolone Derivatives Exhibit Cytotoxicity in Hodgkin’s Lymphoma Cells through NF-ҡB Inhibition and are Synergistic with Doxorubicin and Etoposide” Natarajan Nandakumar, Pushparathinam Gopinath, Jacob Gopas* and Kannoth Manheri Muraleedharan*, Anti-Cancer Agents in Medicinal Chemistry, 2020, 20(6), 715 – 723. 
  9. Functionalizable Oxanorbornane-based Head Group in the Design of New Non-ionic Amphiphiles and Their Drug Delivery Properties, S. Soumya, D. Sirisha Janni,U. Chandrasekhar Reddy, K. M. Muraleedharan, Materials Science & Engineering C, 2020, 112, 110857. 
  10. Synthesis of New Cyclazines and 4,5-Diaryl-1H-pyrrol-3(2H)-one unit in Discoipyrroles from Indolizinone-DMAD Cycloadducts, Jais K., Muraleedharan K. M., Org. Biomol. Chem.  2019, 17 8832 – 8848. 
  11. Electronically-tuned triarylmethine scaffolds for fast and continuous monitoring of H2S levels in biological samples, Kalluruttimmal, Ramshad; Thekke Thattariyil, Divya; Panthalattu Parambil, Archana; Sen, Ashis Kumar; Chakkumkumarath, Lakshmi; Manheri, Muraleedharan Kannoth, Analyst, 2019, 144(14), 4210-4218. 
  12. Rapid measurement of hydrogen sulphide in human blood plasma using a microfluidic method, Karunya, R.; Jayaprakash, K. S.; Gaikwad, R.; Sajeesh, P.; Ramshad, K.; Muraleedharan, K. M.; Dixit, M.; Thangaraj, P. R.; Sen, A. K, Scientific reports, 2019, 9(1), 1-11. 
  13. 1‐Hydroxymethyl‐7‐oxabicyclo[2.2.1]hept‐2‐ene skeleton in enantiopure form through enzymatic kinetic resolution, U. Chandrasekar, Kannoth M. Muraleedharan, Chirality, 2019, 31, 336-347. 
  14. From Helical Supramolecular Arrays to Gel-forming Networks: Lattice-restructuring and Aggregation-control in Peptide-based Sulfamides to Integrate New Functional Attributes, S. V. Raghava, Bhartendu K. Srivastava, K. Ramshad, S. Antharjanam, Babu Varghese, and Kannoth M. Muraleedharan, Soft Matter, 2018, 14, 2357-2364. 
  15. Gel-based Supramolecular ON-OFF Switch from Aryl-triazolyl Peptides with Excellent Chiro-optical-, Thixotropic-, and Self-healing Characteristics, Bhartendu K. Srivastava and Kannoth M. Muraleedharan, Soft Matter, 2018, 14, 1631-1636. 
  16. Serine- and Threonine-derived Diamine Equivalents for Site-specific Incorporation of Platinum Centers in Peptides, and Anticancer Potential of these Conjugates, Sateeshkumar K., Kasipandi V., Soumya Saroj, Nalini V., Karunagaran D and Muraleedharan. K. Manheri, New J. Chem, 2018, 42, 2450-2458. 
  17. Towards a fragment-based approach in gelator design: halogen effects leading to thixotropic, mouldable and self-healing systems in aryl-triazolyl amino acid-based gelators, Bhartendu K. Srivastava and Kannoth M. Muraleedharan, Chem. Commun. 2017, 53, 4485-4488.
  18. Broad spectrum Anti-infective Properties of Benzisothiazolones and the Parallels in their Anti-bacterial and Anti-fungal effects, P. Gopinath, R. K. Yadav, P. K. Shukla, K. Srivastava, S. K. Puri, and K. M. Muraleedharan, Bioorg. MedChem. Lett., 2017, 27(5), 1291-1295. 
  19. Sulfamide Lattice Restructuring to Dimensionally Controlled Molecular Arrays and Gel-forming Systems, S. V. Raghava, P. Gopinath, Bhartendu K. Srivastava, V. Ramkumar, and K. M. Muraleedharan, Chem. Eur. J., 2017, 23, 3658-3665. 
  20. Regio-selective lipase catalyzed hydrolysis of oxanorbornane-based sugar-like amphiphiles at air-water interface: A polarized FT-IRRAS study, Sarangi, Nirod Kumar; Ganesan, M.; Muraleedharan, K. M.; Patnaik, Archita, Chemistry and Physics of Lipids, 2017, 204, 25-33. 
  21. A Modular Approach Towards Drug Delivery Vehicles Using Oxanorbornane-based Non-ionic Amphiphiles, D. Sirisha Janni, U. Chandrasekhar Reddy, Soumya Saroj, K. M. Muraleedharan, Journal of Materials Chemistry B, 2016, 4, 8025 – 8032. 
  22. FtsZ inhibition and Redox modulation with one chemical scaffold: Potential use of Dihydroquinolines against Mycobacteria, Sridevi Duggirala, John Victor Napoleon, Rakesh P. N,Senu Adeeba V., Muraleedharan K. M.,  Mukesh Doble , Eur. J. Med. Chem. 2016, 123, 557-567.
  23. Aryl-triazolyl peptides for efficient phase selective gelation and easy removal of dyes from water, Bhartendu K Srivastava and Kannoth Manneri Muraleedharan, RSC Adv. 2016, 6, 29197-29201. 
  24. N-Methylpyrrolidone Hydroperoxide/Cs2CO3 as an Excellent Reagent System for the Hydroxy-Directed Diastereoselective Epoxidation of Electron-Deficient Olefins Napoleon John Victor, Gana Janardhanan and Kannoth Manheri Muraleedharan, Chem. Eur. J., 2015, 42, 14742-14747. 
  25. Conformational Switching in Heterochiral α,β2,3-Hybrid Peptides in Response to Solvent Polarity, Dhayalan Balamurugan and Kannoth M. Muraleedharan, Eur. J. Org. Chem., 2015, 24, 5321-5325. 
  26. Can Helical Peptides Unwind One Turn at a Time? – Controlled Conformational                 Transitions in α,β2,3-Hybrid Peptides, Dhayalan Balamurugan and Kannoth M. Muraleedharan, Chem. Eur. J, 2015, 21(26), 9332-9338. 
  27. Peptide turns through just ‘one atom’! A sulfamide group nucleates folding and stabilizes new supramolecular topologies in short peptide, Pushparathinam Gopinath, Venkatachalam Ramkumar and   Kannoth Manheri Muraleedharan, CrystEngComm, 2014, 16, 10371-10375. 
  28. Tailoring strained oxanorbornane head-groups to dimensionally controlled nanostructures through hydrogen bonding, Nivarthi Ramesh, M. Ganesan, Nirod Kumar Sarangi, K. M. Muraleedharan and   Archita Patnaik, RSC Adv, 2014, 4, 9762-9770.
  29. An Expeditious and Metal-Free Synthetic Route towards Quinolones, Naphthyridones and Benzonaphthyridones, Napoleon John Victor and Kannoth Manheri Muraleedharan, Adv. Synth. Catal., 2014, 356, 17, 3600-3614. 
  30. Hierarchical Preferences of Hydroxylated Oxanorbornane-Based Achiral Amphiphiles, D. Sirisha Janni and Muraleedharan K. Manheri, Langmuir, 2013, 29, 15182-15190. 
  31. Benzisothiazolones arrest the cell cycle at the G2/M phase and induce apoptosis in HeLa cells, P. Gopinath, K. Ramalingam, Kannoth Manheri Muraleedharan and Devarajan Karunagaran, Med. Chem. Commun. 2013, 4, 749-752. 
  32. N-Substituted 1,2-Dihydroquinolines as Anticancer Agents: Electronic Control of Redox Stability, Assessment of Antiproliferative Effects, and Mechanistic Insights, Napoleon John Victor, Ramasamy Sakthivel, Kannoth Manheri Muraleedharan and Devarajan Karunagaran, ChemMedChem, 2013, 8, 1623-1628.
  33. Chemical Environment as Control Element in the Evolution of Shapes – ‘Hexagons and Rods’ from an 11-Helical α,β2,3-hybrid Peptide, Dhayalan Balamurugan and Kannoth M. Muraleedharan, Soft Matter, 2012, 8, 11857-11862.
  34. Unprecedented Torsional Preferences in trans-β2,3-Amino acid Residues and Formation of 11-Helices in α,β2,3-Hybrid Peptides, Dhayalan Balamurugan and Kannoth M. Muraleedharan, Chem. Eur. J., 2012, 18, 9516-9520. 
  35. Oxanorbornane-based Amphiphilic Systems: Design, Synthesis and Material Properties, M. Ganesan and K. M. Muraleedharan, RSC Adv., 2012, 2, 10, 4048-4051. 
  36. Determination of antimalarial compound, ARB-89 (7β-hydroxy-artemisinin carbamate) in rat serum by UPLC/MS/MS and its application in pharmacokinetics. Pabbisetty, Deepthi; Illendula, Anuradha; Muraleedharan, K. M.; Chittiboyina, Amar G.; Williamson, John S.; Avery, Mitchell A.; Avery, Bonnie A., Journal of Chromato-graphy B: Analytical Technologies in the Biomedical and Life Sciences, 2012, 889-890, 123-129. 
  37. Direct Transformation of Baylis–Hillman Acetates into N-Substituted Quinolones Through an SN2’→SNAr→ (Δ3,4–Δ2,3 Shift)→Oxidation Sequence, John Victor Napoleon, Muraleedharan Kannoth Manheri, Synthesis, 2011, 20, 3379-3388. 
  38. Highly Chemoselective Esterification Reactions and Boc/THP/TBDMS Discriminating Deprotections under Samarium(III) Catalysis, Gopinath Pushparathinam, Nilaya Surapaneni and Muraleedharan Kannoth Manheri, Org. Lett., 2011, 13, 1932-1935. 
  39. Multi-chelation approach towards natural product-like skeletons: one-pot access to a nitrogen-containing tetracyclic framework from AlaAla dipeptide, Kasipandi Vellaisamy, John Victor Napoleon, Ramkumar Venkatachalam and Muraleedharan Kannoth Manheri, Chem. Commun., 2010, 46, 9212-9214.
  40. Synthesis of β-Hydroxy-phosphonate and 1,3-dihydroxy acyclic nucleoside analogs via 1,3 dipolar cycloaddition strategy, Ganesan M. and Muraleedharan K. M., Nucleosides, Nucleotides and Nucleic acids, 2010, 29, 91-96.
  41. Trans-β2,3-amino acid-based supramolecular synthons for probing the interrelationships between structure, torsion-directed assembly and isomorphism, Balamurugan Dhayalan, Ramkumar Venkatachalam and Muraleedharan Kannoth Manheri, Crystal Growth and Design, 2010, 10, 2460-2464. 
  42. An efficient synthetic approach towards trans-β2,3-amino acids and demonstration of their utility in the design of therapeutically important β2,3-peptides and α,β2,3-peptide aldehydes, Balamurugan Dhayalan, Muraleedharan Kannoth Manheri, Tetrahedron, 2009, 65, 10074-10082. 
  43. As many as six tandem reactions in one step! – Unprecedented formation of highly functionalized benzothiophenes, Gopinath Pushparathinam, Nilaya Surapaneni, Debiranjan Tripathy, Ramkumar Venkatachalam, and Muraleedharan Kannoth Manheri, Chem. Commun., 2009, 46, 7131-7133.
  44. A New Library of C-9 modified Artemisinin Analogs and Evaluation of their Anti-parasitic Activities, Menon, Rani B., K. Muraleedharan M., Tekwani, Babu L.; Gut, Jiri, Rosenthal, Phillip J., and Avery, Mitchell A., Combinatorial Chemistry & High Throughput Screening, 2006, 9, 729-741. 
  45. Microbial transformation of Artemisinin to 5-Hydroxyartemisinin by Eurotium amstelodami and Aspergillus niger, Parshikov, I. A.; Miriyala, B.; Muraleedharan, K. M.; Avery, M. A. and Williamson, J. S., Ind. Microbiol. Biotechnol., 2006, 33, 349-352.
  46. Biocatalysis of the anti-malarial artemisinin by Mucor ramannianus strains, Parshikov, I.A.; Miriyala, B.; Muraleedharan, K. M.; Illendula, A.; Avery, M. A. and Williamson, J. S., Pharmaceutical Biology, 2005, 43, 579-582. 
  47. Transformation of artemisinin by Cunninghamella elegans, I. A. Parshikov; K. M. Muraleedharan; M. A. Avery and J. S. Williamson, Appl. Microbiol. Biotechnol., 2004, 64, 782-786. 
  48. Hydroxylation of 10-Deoxoartemisinin by Cunninghamella elegans, I. A. Parshikov; K. M. Muraleedharan; M. A. Avery; J. S. Williamson, J. Nat. Prod., 2004, 67, 1595-1597.
  49. Structure-Activity Relationships of the Antimalarial Agent Artemisinin 8. Design, Synthesis and CoMFA Studies towards the Development of Artemisinin Based Drugs against Leishmaniasis and Malaria, Mitchell A. Avery; Kannoth M Muraleedharan; Prashant V. Desai; A. K. Bandhyopadhyaya; Babu L. Tekwani; and Marise Furtado, J. Med. Chem., 2003, 46, 4244-4258.
  50. Unique assemblies of alternating positively and negatively charged layers, directed by hydrogen bonds, ionic interactions and π-stacking in the crystal structures of complexes between mellitic acid (benzene hexacarboxylic acid) and five planar aromatic bases, Karle Isabella; Gilardi, Richard D.; Ch.Chandrashekhar Rao; K. M. Muraleedharan; and Subramania Ranganathan, J. Chemical Crystallography, 2003, 33 10, 727-749. 
  51. The design and synthesis of redox core-alpha amino acid composites based on thiol-disulfide exchange mechanism and a comparative study of their zinc abstraction potential from [CCXX] boxes in proteins, Subramania Ranganathan; K. M. Muraleedharan; Parimal Bharadwaj; Dipankar Chatterji and Isabella Karle, Tetrahedron, 2002, 58, 2861-2874. 
  52. Unusual cyclo–tetra and hexa peptidation of bis Boc cystine with cystine-diOMe: One step preparation of the novel 32-and 48-membered cyclo – tetra cystine and cyclo-hexa cystine, S. Ranganathan; K. M. Muraleedharan; M. Vairamani; A. C. Kunwar; A. Ravi Sankar, Chem. Commun., 2002, 314-315.
  53. One step transformation of Tricyclopentabenzene (Trindane, C15H18) to Bicyclo(10.3.0)pentadec-1(12)ene-2,6,7,11-tetrone (C15H18O4) and its Aldol Product,12-Hydroxy-16-oxatetracyclo(10.3.0.1,507,11)hexadec-7(11)ene-2,6-dione(C15H18O4), Subramania Ranganathan; K. M. Muraleedharan; Ch. Chandrashekhar Rao; M.Vairamani; and Isabella L. Karle, Org. Lett., 2001, 3 (16), 2447-2449. 
  54. Stacking of a benzenehexacarboxylic acid core in the crystal structure of benzenehexacarboxylic acid – aminomethyl isobutyrate amide (MA-Aib6)-sodium nitrate complex, Ranganathan, Subramania; Muraleedharan, K. M.; Chandrashekhar Rao, C. H.; Vairamani, M.; Karle, Isabella L.; Gilardi, Richard D., Chem. Commun. 2001, 24, 2544-2545. 
  55. The preference profile in ruthenium tetroxide oxidations, Ranganathan, S.; Muraleedharan, K. M.; Bhattacharya, D.; Kundu, D, J. Indian Chem. Soc. 1998, 10-12 (75), 583-589.
  56. One step transformation of tricyclopentabenzene (trindane) [C15H18] to 4-[1R,2S,4R,5S)-1,2,5-trihydroxy-3-oxabicyclo[3.3.0]octane-4 spiro-1′-(2′-oxocyclopentan)-2-yl]butanoic acid [C15H22O7], Ranganathan, Subramania; Muraleedharan, K. M.; Bharadwaj, Parimal; Madhusudanan, K. P., Chem. Commun., 1998, 20, 2239-2240.
   
  1. 1H-pyrrol-3(2H)-one scaffold for the design of multimodal diagnostic probes and therapeutic agents, Muraleedharan Kannoth Manheri, Archana Panthalattu Parambil, Jais Kurian, Akila Kesavan, Patent Application No: 202241034179; date of Filing: 15/06/2022 (IDF 2353, IIT Madras)
  2. Method for selective quantification of hydrogen sulfide, Muraleedharan Kannoth Manheri, Lakshmi Chakkumkumarath, Ramshad Kalluruttimmal, Divya Thekke Thattariyil, Indian Pat. Appl. (2019), IN 201741043637 A 20191206. PCT Int. Appl. (2019), WO 2019111268 A1 20190613, ICSR IDF No. 1559, Patent No.: 391511; date, 05.12.2017 (Granted)
  3. Drug delivery applications of oxanorbornane-based amphiphiles, K. M. Muraleedharan, U Chandrasekhar Reddy, Soumya Saroj, Devi Sirisha Janni, Indian Pat. Appl. (2018), IN 201641037950 A 20180511; Patent No. 347372 date: 07-11-2016, (Granted)
  4. Preparation of purinylquinolone derivatives for use as kinase ATP binding site modulators, K. M. Muraleedharan, D. Prabakaran and N. J. Victor, Indian Pat. Appl. (2016), IN 2014CH05646 A 20161111, date: 10-05-2015, (Granted)
  5. N-Methylpyrrolidinone hydroperoxide as an efficient epoxidation reagent for preparation of oxiranes and related compounds, Muraleedharan, Kannoth Manheri and Victor, Napoleon John, Indian Pat. Appl. (2015), IN 2013CH06186 A 20150925, date: 31-12-2013, (Granted)
  6. A process for the preparation of quinolone derivatives and analogs, Muraleedharan, Kannoth Manheri; John, Victor Napoleon, Indian patent application 1542/CHE/2012 on 18-04-2012; PCT Int. Appl. (2013), WO 2013157018 A1 20131024, date: 23-05-2018, (Granted)
  7. Preparation of artemisinin-based peroxide compounds as broad-spectrum anti-infective agents, Mitchell A. Avery, Muraleedharan Kannoth M., PCT Int. Appl. (2003), WO 2003095444 A1 20031120
  8. One pot ozonolysis transformation of tricyclopentabenzene (trindane) to 12- Hydroxy-16-Oxatetracyclo [10.3.1.01,5.07,11]hexadec-7(11)en-2,6-dione, S. Ranganathan, Kannoth Manheri Muraleedharan, United States patent # 2002137951 A1; IN 2001DE00339
  9. Benziso-N (L-Histidine methylester)-thiazolone, process for the preparation thereof, and Use thereof, for RNA Polymerase Inhibition, S. Ranganathan, Kannoth Manheri Muraleedharan, United States patent # 6,350,879 B1; Indian, 2004, IN 194998 A1 20041218
  1. Progress in the development of peroxide-based anti-parasitic agents, K. M. Muraleedharan and Mitchell A. Avery, Drug Discovery Today, 2009, 14, 15/16, 793-803.
  2. Parasitic diseases: Advances in the discovery of new anti-malarials, K. M. Muraleedharan and Mitchell A. Avery, Comprehensive Medicinal Chemistry-II, 2006, 7, 765-814.
  3. Halo- and selenolactonisation: The two major strategies for cyclofunctionalization, Subramania Ranganathan; K. M. Muraleedharan; Narendra K. Viash and Narayanaswami Jayaraman, Tetrahedron, 2004, 60, 5273-5308.
  4. Contribution in Continuing education programs: Wrote a Chapter for engineering chemistry III online study material for NPTEL program (http://nptel.iitm.ac.in/courses/IIT-MADRAS/Engineering_Chemistry_III/index.php).

 

S. No

Title

Cost in Lakhs

Month of submission

Role 

PI/Co-PI

Agency

Status

1

New synthetic peptides for targeting PCSK9 towards next generation anti-hypercholesterolemic drugs

76.6

15-Feb-24

To

14-Feb-2027

PI

SERB

Ongoing

2

Micro Nano Bio Fluidics (C-MNBF) Centre

537.66

Feb 2021 to

Feb 2024

Co-PI

IITM

Ongoing

 

S. No

Title

Cost in Lakhs

Duration

Role 

PI/Co-PI

Agency

Status

1

Optimization/development of cost effective, eco-friendly and pharmacopoeially acceptable synthesis of Moxifloxacin and the key starting materials (Phase II)

16.94

Apr 2023 to Feb 2024

PI

Global Pharma

Completed

2

Effective pathways (eco-friendly/cost effective & pharmacopoeially acceptable) synthesis of ofloxacin and related drugs

13.3

Jul 2021 to

Sep 2022

PI

Global Pharma

Completed

3

Microfluidic platform for continuous monitoring of gasotransmitters for early level management of Systemic Inflammatory Response Syndrome (SIRS) in Trauma patients

374.92

July 2016 to

July 2019

Co-PI

DST IMPRINT Proposal

Completed

4

Peptide-based Mutual Pro-drugs for Dual Inhibition of Key Protein Components in Cancer Cell Signalling

49.89

18-Aug-17

To

17-Feb-2021

PI

DST-SERB

Completed

5

Peptide-based supramolecular matrices for the topical delivery of Cyclosporine in psoriasis treatment

8.5 lakhs

2020 Dec

To 2021 March

PI

IIT Madras

(ERP)

Completed

6

Nanomolecular aggregates from glycolipid mimics and cyclic peptides with applications in drug delivery, membrane engineering and vaccine development

49.80

Oct 2013- 

Oct 2016

PI

DST nano mission

Completed

7

Platinum-Loaded Foldamers as New Generation Cancer Chemotherapeutic agents

10.0

Feb 2015- Aug 2016

PI

IIT Madras

(Exploratory research grant)

Completed

8

Center For Research on Confined Soft Matter

207

Dec 2014 – Nov 2016

Co-PI

IIT Madras

Completed

9

Kinase Drug Discovery b 

29.77 lakhs

Nov 2013-Nov/2014

Co-PI

Parthy’s Reverse informatics

Completed

10

‘β2,3-peptides with lateral and longitudinal amphipathicities: New models to study lipid-peptide interactions with potential application in antibiotic development’

35.47

Nov 2007- Feb 2011

PI

DST

Completed

11

ATP-Substrate Transition State Analogs: A Rational Approach to Target Insulin-Like Growth Factor Receptor-1 Kinase

14.46

May 2007 Nov 2010

PI

CSIR

Completed